185 results
Page 4 of 10
S-8 POS
m8obczrok2njp34vb 4k
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:23pm
S-8 POS
enxwirbo
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:23pm
S-8 POS
EX-23.2
imb6as2k
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:23pm
S-8 POS
EX-23.2
7ej7d9rc
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:23pm
S-8 POS
blwyn470mqiwtyyv
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:23pm
S-8 POS
2v2xudtcea
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:22pm
S-8 POS
EX-23.2
judc4nekusom
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:22pm
S-8
EX-23.2
u6pjqi5
9 Aug 21
Registration of securities for employees
4:56pm
S-8
qs8jakf905b6 q45fob
9 Aug 21
Registration of securities for employees
4:56pm
8-K
EX-1.1
21tycuz
9 Aug 21
Entry into a Material Definitive Agreement
4:48pm
424B5
a6atox7tmz6qsxyae
9 Aug 21
Prospectus supplement for primary offering
4:43pm
8-K
wcxjzsyygnk
22 Jul 21
Ocular Therapeutix™ Announces Second Quarter 2021 Preliminary Net Product Revenue of $11.7 Million
4:33pm
8-K
h56tml0muqclm
22 Jun 21
Departure of Directors or Certain Officers
4:14pm
8-K
EX-10.1
fi0swox
4 Jun 21
Entry into a Material Definitive Agreement
4:34pm
DEFA14A
3ag6b aa3vbyixr2e
29 Apr 21
Additional proxy soliciting materials
4:18pm
8-K
bhfdqk5 4w
29 Apr 21
Results of Operations and Financial Condition
6:31am